1. Home
  2. BRID vs ANIX Comparison

BRID vs ANIX Comparison

Compare BRID & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgford Foods Corporation

BRID

Bridgford Foods Corporation

HOLD

Current Price

$7.69

Market Cap

72.8M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.20

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRID
ANIX
Founded
1932
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.8M
135.3M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
BRID
ANIX
Price
$7.69
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.00
AVG Volume (30 Days)
2.8K
448.6K
Earning Date
01-28-2026
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$227,364,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.24
$2.07
52 Week High
$10.83
$5.46

Technical Indicators

Market Signals
Indicator
BRID
ANIX
Relative Strength Index (RSI) 48.40 37.08
Support Level $7.26 $3.23
Resistance Level $8.50 $3.44
Average True Range (ATR) 0.25 0.40
MACD -0.06 -0.11
Stochastic Oscillator 32.26 1.15

Price Performance

Historical Comparison
BRID
ANIX

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: